At the 14th International ISSX Meeting in Chicago, we unveiled compelling new data for the TruVivo® all-human hepatocyte co-culture model.
This research, presented by Kevin Johnson, details how the TruVivo system is going beyond conventional in vitro assays. In addition to delivering robust results for metabolic clearance and metabolite ID, the data demonstrates its remarkable ability to distinguish the hepatotoxicity of closely related drugs.
This level of precision accelerates drug development by providing highly human-relevant safety insights. For a detailed look at these findings, download our poster today.
